These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27456487)

  • 41. Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5' inositol phosphatase (SHIP).
    Brauweiler A; Tamir I; Dal Porto J; Benschop RJ; Helgason CD; Humphries RK; Freed JH; Cambier JC
    J Exp Med; 2000 May; 191(9):1545-54. PubMed ID: 10790429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation.
    Bai X; Zhang Y; Huang L; Wang J; Li W; Niu L; Jiang H; Dai R; Zhou L; Zhang Z; Miller H; Song W; Zhao X; Liu C
    Blood; 2016 Sep; 128(13):1723-34. PubMed ID: 27330000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells.
    Rieth N; Carle A; Müller MA; ter Meer D; Direnberger C; Pohl T; Sondermann P
    Immunol Lett; 2014 Aug; 160(2):145-50. PubMed ID: 24472604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP.
    Chacko GW; Tridandapani S; Damen JE; Liu L; Krystal G; Coggeshall KM
    J Immunol; 1996 Sep; 157(6):2234-8. PubMed ID: 8805618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways.
    Wang Z; Zhou H; Yue X; Zhu J; Yang Y; Liu M
    Anal Bioanal Chem; 2022 Jan; 414(1):497-506. PubMed ID: 34021368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
    Preissler MT; Kaiser L; Drake JR; Gosselin EJ
    Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.
    Aman MJ; Lamkin TD; Okada H; Kurosaki T; Ravichandran KS
    J Biol Chem; 1998 Dec; 273(51):33922-8. PubMed ID: 9852043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
    Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
    Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location.
    Phee H; Jacob A; Coggeshall KM
    J Biol Chem; 2000 Jun; 275(25):19090-7. PubMed ID: 10764758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
    Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
    J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.
    Marshall AJ; Niiro H; Yun TJ; Clark EA
    Immunol Rev; 2000 Aug; 176():30-46. PubMed ID: 11043766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization.
    Carver DJ; Aman MJ; Ravichandran KS
    Blood; 2000 Aug; 96(4):1449-56. PubMed ID: 10942391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What goes up must come down: A tripartite Dok-3/Grb2/SHIP1 inhibitory module limits BCR signaling.
    Reth M; Gold MR
    Eur J Immunol; 2016 Nov; 46(11):2507-2511. PubMed ID: 27813071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional consequences of a MAPK docking site on human FcgammaRIIb.
    Medgyesi D; Sárközi R; Koncz G; Arató K; Váradi G; Tóth GK; Sármay G
    Immunol Lett; 2004 Mar; 92(1-2):83-90. PubMed ID: 15081531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative regulation of mast cell proliferation by FcgammaRIIB.
    Malbec O; Attal JP; Fridman WH; Daëron M
    Mol Immunol; 2002 Sep; 38(16-18):1295-9. PubMed ID: 12217398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.
    Ono M; Bolland S; Tempst P; Ravetch JV
    Nature; 1996 Sep; 383(6597):263-6. PubMed ID: 8805703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor.
    Georgescu MT; Moorehead PC; Liu T; Dumont J; Scott DW; Hough C; Lillicrap D
    Front Immunol; 2020; 11():138. PubMed ID: 32117285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling.
    D'Ambrosio D; Fong DC; Cambier JC
    Immunol Lett; 1996 Dec; 54(2-3):77-82. PubMed ID: 9052858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.